Helius Medical Technologies, Inc.
HSDT
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis andā¦ read more
Healthcare
Medical Devices
11 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$2.98
Price+3.12%
$0.09
1Y
Price
Market Cap
$120.094m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-50517.1%
EBITDA Margin-50612.3%
Net Profit Margin-580.2%
Free Cash Flow MarginRevenue
$941k
+81.0%
1y CAGR+14.5%
3y CAGR+23.6%
5y CAGREarnings
-$370.367m
-3054.2%
1y CAGR-1016.6%
3y CAGR-756.8%
5y CAGREPS
-$39.75
-818.0%
1y CAGR-235.1%
3y CAGR-154.9%
5y CAGRBook Value
-$152.392m
$475.920m
Assets$628.312m
Liabilities-
DebtDebt to Assets
0.0%
-
Debt to EBITDAFree Cash Flow
-$12.715m
-15.1%
1y CAGR+2.1%
3y CAGR-0.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company